These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32356373)

  • 1. Angioedema-like contact dermatitis caused by mesotherapy with dutasteride.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Alonso-Carpio M; Talamantes CS; Zaragoza-Ninet MG; Zaragoza-Ninet V
    Contact Dermatitis; 2020 Sep; 83(3):246-247. PubMed ID: 32356373
    [No Abstract]   [Full Text] [Related]  

  • 2. sQuiz your knowledge: Polycyclic annular plaques on the trunk following dutasteride treatment.
    Ruiz-Villaverde R; Ayen-Rodriguez A; Llamas-Molina JM
    Eur J Dermatol; 2020 Aug; 30(4):452-453. PubMed ID: 32969816
    [No Abstract]   [Full Text] [Related]  

  • 3. Palpebral angioedema and allergic contact dermatitis caused by a cerumenolytic.
    Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
    Contact Dermatitis; 2015 Dec; 73(6):376-7. PubMed ID: 26179134
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesotherapy with dutasteride for androgenetic alopecia: a concise review of the literature.
    Rodríguez-Cuadrado FJ; Pinto-Pulido EL; Fernández-Parrado M
    Eur J Dermatol; 2023 Feb; 33(1):72. PubMed ID: 37178048
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
    Arias-Santiago S; Camacho-Martínez FM
    Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
    [No Abstract]   [Full Text] [Related]  

  • 6. 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.
    Kang MJ; Choi JY; Sim WY; Lew BL
    J Am Acad Dermatol; 2021 Jan; 84(1):172-173. PubMed ID: 32320771
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic contact dermatitis mimicking angioedema due to paraphenylendiamine hypersensitivity: a case report.
    Tukenmez Demirci G; Kivanc Altunay I; Atis G; Kucukunal A
    Cutan Ocul Toxicol; 2012 Sep; 31(3):250-2. PubMed ID: 22181557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angioedema associated with dutasteride therapy.
    Kampitak T; Binkley K
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):376-7. PubMed ID: 21962103
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.
    Dhurat R; Sharma A; Rudnicka L; Kroumpouzos G; Kassir M; Galadari H; Wollina U; Lotti T; Golubovic M; Binic I; Grabbe S; Goldust M
    Dermatol Ther; 2020 May; 33(3):e13379. PubMed ID: 32279398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice.
    Saceda-Corralo D; Moustafa F; Moreno-Arrones Ó; Jaén-Olasolo P; Vañó-Galván S; Camacho F
    J Drugs Dermatol; 2022 Jul; 21(7):742-747. PubMed ID: 35816059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Lee S; Lee YB; Choe SJ; Lee WS
    Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia.
    Tsai TF; Choi GS; Kim BJ; Kim MB; Ng CF; Kochhar P; Jasper S; Brotherton B; Orban B; Lulic Z
    J Dermatol; 2018 Jul; 45(7):799-804. PubMed ID: 29667763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.
    Moftah N; Moftah N; Abd-Elaziz G; Ahmed N; Hamed Y; Ghannam B; Ibrahim M
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):686-93. PubMed ID: 22486925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia.
    Tsunemi Y; Irisawa R; Yoshiie H; Brotherton B; Ito H; Tsuboi R; Kawashima M; Manyak M;
    J Dermatol; 2016 Sep; 43(9):1051-8. PubMed ID: 26893187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
    Fertig RM; Gamret AC; Darwin E; Gaudi S
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folliculocentric Mycosis Fungoides Masquerading as Angioedema and Allergic Contact Dermatitis.
    Jiang SY; Yeh J; Novoa R; Wang E; Chen M
    J Allergy Clin Immunol Pract; 2024 Jul; 12(7):1905-1906. PubMed ID: 38727652
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs.
    Pirozzi Farina F; Pischedda A
    Arch Ital Urol Androl; 2016 Jan; 87(4):312-6. PubMed ID: 26766804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photosensitivity associated with dutasteride therapy.
    Espasandín-Arias M; García-Rodiño S; Suárez-Peñaranda JM; Rodríguez-Granados MT
    J Dtsch Dermatol Ges; 2020 Apr; 18(4):375-377. PubMed ID: 32291925
    [No Abstract]   [Full Text] [Related]  

  • 20. Angioedema-like allergic contact dermatitis to castor oil.
    Sánchez-Guerrero IM; Huertas AJ; López MP; Carreño A; Ramírez M; Pajarón M
    Contact Dermatitis; 2010 May; 62(5):318-9. PubMed ID: 20536483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.